Global Heart Scan Market Size, Share, Forecast Report, 2020-2027

A heart scan, also known as a coronary calcium scan is a specialized X-ray test which provides images of heart that enable the detection and measurement of calcium-containing plaque in the arteries. During the last few years, there has been a significant increase in the demand for cardiovascular devices. According to the World Health Organization (WHO), in 2015, over 17.7 million people died from cardiovascular diseases, representing 31% of all global deaths of which 82% were in the low- and middle-income countries. Additionally, according to the Centers for Disease Control and Prevention (2015), over 630,000 Americans die from heart disease each year, which accounts for 1 in every 4 death. The global heart scan market is expecting a sound growth in coming future owing to the increasing demand for various cardiovascular devices, increasing prevalence of cardiovascular diseases, and favorable reimbursement policies. Mostly all diabetic patients suffer from some or the other cardiovascular disease. According to findings from the WHO in 2014, approximately 422 million people reported suffering from diabetes. Due to the increasing diabetic population across the globe, there is a significant increase in the number of people suffering from cardiovascular diseases. Additionally, increasing geriatric population and increasing healthcare expenditure have fuelled the growth of the market. On the other hand, strict regulatory rules and the high cost of the diagnostic tests may slow the growth of the market during the forecast period.
Segments
The global heart scan market has been segmented on the basis of types, indication and end users.

On the basis of the types, the global heart scan market is segmented into electron beam computed tomography, nuclear heart scan, echocardiogram, cardiac catheterization, coronary arteriography, angiocardiography, and others.

Based on the indication, it is segmented into congenital heart disease, coronary arteries blockage, defects or injury to the heart’s four primary valves, blood clots within the heart’s chambers, tumors in or on the heart, and others.
On the basis of the end users, the market is segmented into hospitals & clinics, diagnostic centers, cardiac care centers, ambulatory centers & home care, academic institutes, and others.

Key players in the global heart scan market:
Some of the major players in this market are Boston Scientific Corporation (U.S.), Coloplast (Denmark), Dispocard GmbH (Germany), St. Jude Medical (U.S.), Abbott Laboratories (U.S.), Johnson & Johnson (U.S.), Teleflex Incorporated (U.S.)., Smiths Medical (U.S.), Edwards Life Sciences Corporation (U.S.), Medtronic Inc (U.S.), Rochester Medical Corporation (U.S), Maquet Medical India Private Limited (India), Terumo Medical Corporation (Japan) and others.